Financhill
Back

Arcturus Therapeutics Holdings Vs. Simulations Plus Industry Stock Comparison

Sell
47

ARCT
Arcturus Therapeutics Holdings

Last Price:
23.88
Seasonality Move:
-7.1%
Sell
30

SLP
Simulations Plus

Last Price:
30.22
Seasonality Move:
4.76%
Sell
47
Arcturus Therapeutics Holdings (ARCT) is a Sell

Is Arcturus Therapeutics Holdings a Buy, Sell or Hold?

  • The current Arcturus Therapeutics Holdings [ARCT] share price is $23.89. The Score for ARCT is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • ARCT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Simulations Plus (SLP) is a Sell

Is Simulations Plus a Buy, Sell or Hold?

  • The current Simulations Plus [SLP] share price is $30.22. The Score for SLP is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • SLP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ARCT Stock Price Chart

What is Arcturus Therapeutics Holdings's stock price today?

  • The Arcturus Therapeutics Holdings share price today is $23.89
    The current trend is moderately bullish and ARCT is experiencing selling pressure, which indicates risk of future bearish movement.

SLP Stock Price Chart

What is Simulations Plus's stock price today?

  • The Simulations Plus share price today is $30.22
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SLP is experiencing selling pressure, which indicates risk of future bearish movement.

ARCT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.98 Buy
Relative Strength Index (14 RSI): 60.47 Buy
Chaikin Money Flow: -107213 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.37 - 23.17) Buy
Bollinger Bands (100): (19 - 30.76) Sell

SLP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.31 Sell
Relative Strength Index (14 RSI): 30.89 Sell
Chaikin Money Flow: -69284 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (30.76 - 33.9) Sell
Bollinger Bands (100): (33.91 - 46.71) Sell

ARCT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23.46 Buy
20-day SMA: 21.74 Buy
50-day SMA: 21.08 Buy
200-day SMA: 28.98 Sell
8-day EMA: 23.62 Buy
20-day EMA: 22.35 Buy
50-day EMA: 22.22 Buy
200-day EMA: 25.93 Sell

SLP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 30.96 Sell
20-day SMA: 31.69 Sell
50-day SMA: 34.89 Sell
200-day SMA: 41.59 Sell
8-day EMA: 30.92 Sell
20-day EMA: 31.96 Sell
50-day EMA: 34.8 Sell
200-day EMA: 40.17 Sell

Arcturus Therapeutics Holdings Earnings Growth & ARCT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $1.49 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and an increase next year of $1.47 per share.

Simulations Plus Earnings Growth & SLP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and an increase next year of $0.08 per share.

Arcturus Therapeutics Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Simulations Plus Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):